Tecan Cavro pumps help oceanographic research
2 September 2009, News release from Tecan Group Ltd
The Japan Agency for Marine-Earth Science and Technology (JAMSTEC) has developed a miniaturized observation device to measure carbon dioxide (CO2) in seawater, relying on Tecan's Cavro® XCalibur Pump for accurate automated pipetting.
JAMSTEC is involved in a wide range of basic marine-related research, including collection and dissemination of information that helps to understand changes in the earth's environment. It is one of the activities of the Japan EOS Promotion Program, funded by MEXT, Japan.
"It is necessary to monitor CO2 concentrations in order to predict future climate change," explained Dr Yoshiyuki Nakano, Research Scientist at JAMSTEC's Mutsu Institute for Oceanography in Aomori, Japan. "We developed a device that calculates the CO2 concentration in seawater by analyzing a pH indicator solution, using two Cavro XCalibur Pumps to aspirate and mix pure water and concentrated pH indicator for each measurement.
The volumes of indicator and water used are critical for reliable results, and the accuracy of the Cavro XCalibur Pump allows us to achieve exactly the concentration we aim for, while the pump's broad selectable volume range allows us to choose the exact concentration we want."
"We also chose the Cavro XCalibur Pump because an important design goal was to make the CO2 sensor small and light; the pump also offered high accuracy and was capable of maintenance-free operation for long periods," added Dr Nakano.
For more information about Tecan, please contact:
Tecan Group Ltd
T +41 44 922 81 11,
F +41 44 922 81 12
Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics.
The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories.
Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).
For further information please email Tecan Group Ltd